Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Oncotarget|August 31, 2015
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?Giuseppe Bronte, Nicola Silvestris, Marta Castiglia, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspectsGiuseppe Bronte, Christian Rolfo, Elisa Giovannetti, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 5, 2016
Dietary restriction: could it be considered as speed bump on tumor progression road?Antonina Cangemi, Daniele Fanale, Gaetana Rinaldi, et al.
Frontiers in Immunology|May 2, 2022
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory AnalysisGiuseppe Bronte, Elisabetta Petracci, Serena De Matteis, et al.
Critical Reviews in Oncology/Hematology|April 30, 2015
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysisGiuseppe Bronte, Christian Rolfo, Francesco Passiglia, et al.
Expert Opinion on Therapeutic Targets|May 20, 2014
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?Daniele Fanale, Juan Lucio Iovanna, Ezequiel Luis Calvo, et al.
Oncology|January 10, 2014
Well-being among Italian medical oncologists: an exploratory studyAntonio Russo, Rossella De Luca, Giuseppe Cicero, et al.
Frontiers in Immunology|June 14, 2021
Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint InhibitorsGiuseppe Bronte, Alberto Verlicchi, Serena De Matteis, et al.
Frontiers in Immunology|January 23, 2024
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dreamLuana Calabrò, Giuseppe Bronte, Federica Grosso, et al.
Cells|December 11, 2022
Replicative Senescence-Associated LINE1 Methylation and LINE1-Alu Expression Levels in Human Endothelial CellsDeborah Ramini, Silvia Latini, Angelica Giuliani, et al.
Pageof 11